Ligand validation:3M30

EDO: 1,2-ETHANEDIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3M30_EDO_B_446	79%	80%	0.085	0.929	0.53	0.31	-	-	0	0	100%	1
3M30_EDO_D_556	65%	73%	0.094	0.895	0.48	0.58	-	-	1	0	100%	1
3M30_EDO_F_251	55%	68%	0.109	0.877	0.64	0.58	-	-	1	0	100%	1
3M30_EDO_C_251	47%	73%	0.132	0.87	0.56	0.5	-	-	0	0	100%	1
3M30_EDO_F_252	35%	75%	0.155	0.842	0.76	0.23	-	-	3	0	100%	1
3M30_EDO_A_557	27%	61%	0.113	0.759	0.79	0.7	-	-	0	0	100%	1
3M2R_EDO_D_556	51%	71%	0.093	0.846	0.56	0.57	-	-	0	0	100%	1
6ANS_EDO_A_404	100%	89%	0.029	0.995	0.57	0.07	-	-	0	0	100%	1
4ITB_EDO_A_503	100%	88%	0.028	0.99	0.38	0.29	-	-	0	0	100%	1
4FQI_EDO_A_401	100%	85%	0.032	0.992	0.46	0.29	-	-	0	0	100%	1
4KXW_EDO_A_1003	100%	73%	0.033	0.993	0.64	0.4	-	-	0	0	100%	1
8JK3_EDO_A_304	100%	81%	0.033	0.992	0.22	0.58	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.